Delivery Order SPE2DB24D2205-SPE2DB25FEEWG
Award Date 7/14/25
Potential Completion Date 8/4/25
Potential Value $4.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,322.04 to AmerisourceBergen Drug Corp for XOLAIR 150 mg/mL syringes. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of July 25, 2025. AmerisourceBergen will perform the delivery order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,762.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XOLAIR 150 mg/mL syringes, with an ultimate completion date of August 28, 2025. This non-set-aside competitive award was issued on August 7, 2025, and represents a direct order fulfillment from AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for XOLAIR 150 mg/ml syringes valued at $8,644.08 with a firm fixed price contract type. The delivery order is scheduled for completion by September 5, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,440.70 for XOLAIR 150 mg/mL syringes under a firm fixed price contract type. The award was made on August 5, 2025, with an ultimate completion date of August 26, 2025. This delivery order represents a non-competitive, non-set-aside procurement and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $4,322.04 firm fixed price delivery order to AmerisourceBergen Drug Corp for XOLAIR 150 mg/mL syringes with a completion date of August 28, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare...
- The Defense Logistics Agency awarded a $6,928.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of XOLAIR 300 mg/2 ml syringes. The contract, which is classified as a non-set-aside competitive award, is scheduled for completion by August 25, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of XOLAIR 150 mg/ml syringes, with a contract ceiling value of $5,762.72 and an ultimate completion date of August 19, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation, performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XOLAIR 300 mg/2 mL syringes with a ceiling value of $1,732.19. This competitively awarded, non-set-aside contract was issued on July 22, 2025, with an ultimate completion date of August 12, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, under firm fixed pricing terms. This delivery order is issued against AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a Delivery Order valued at $1,440.70 to AmerisourceBergen Drug Corp for the supply of Xolair 150 mg/ml syringes, with an ultimate completion date of September 9, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under a larger indefinite delivery contract vehicle. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,161.02 to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Xolair 150 mg/ml syringes. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 11, 2025. The contract is to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...